Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Oxid Med Cell Longev ; 2022: 7925686, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35847585

RESUMEN

Progressive accumulation of misfolded SNCA/α-synuclein is key to the pathology of Parkinson's disease (PD). Drugs aiming at degrading SNCA may be an efficient therapeutic strategy for PD. Our previous study showed that mesencephalic astrocyte-derived neurotrophic factor (MANF) facilitated the removal of misfolded SNCA and rescued dopaminergic (DA) neurons, but the underlying mechanisms remain unknown. In this study, we showed that AAV8-MANF relieved Parkinsonian behavior in rotenone-induced PD model and reduced SNCA accumulation in the substantia nigra. By establishing wildtype (WT) SNCA overexpression cellular model, we found that chaperone-mediated-autophagy (CMA) and macroautophagy were both participated in MANF-mediated degradation of SNCAWT. Nuclear factor erythroid 2-related factor (Nrf2) was activated to stimulating macroautophagy activity when CMA pathway was impaired. Using A53T mutant SNCA overexpression cellular model to mimic CMA dysfunction situation, we concluded that macroautophagy rather than CMA was responsible to the degradation of SNCAA53T, and this degradation was mediated by Nrf2 activation. Hence, our findings suggested that MANF has potential therapeutic value for PD. Nrf2 and its role in MANF-mediated degradation may provide new sights that target degradation pathways to counteract SNCA pathology in PD.


Asunto(s)
Enfermedad de Parkinson , alfa-Sinucleína , Autofagia/fisiología , Neuronas Dopaminérgicas/metabolismo , Humanos , Factor 2 Relacionado con NF-E2/metabolismo , Factores de Crecimiento Nervioso/metabolismo , Enfermedad de Parkinson/tratamiento farmacológico , alfa-Sinucleína/genética , alfa-Sinucleína/metabolismo
2.
Interdiscip Sci ; 7(1): 65-77, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25792441

RESUMEN

Single nucleotide polymorphisms (SNPs) make up the most common form of mutations in human cytochrome P450 enzymes family, and have the potential to bring with different drug responses or specific diseases in individual patients. Here, based on machine learning technology, we aim to explore an effective set of sequence-based features for improving prediction of SNPs by using support vector machine algorithms. The features are derived from the target residues and flanking protein sequences, such as amino acid types, sequences composition, physicochemical properties, position-specific scoring matrix, phylogenetic entropy and the number of possible codons of target residues. In order to deal with the imbalance data with a majority of non-SNPs and a minority of SNPs, a preprocessing strategy based on fuzzy set theory was applied to the datasets. Our final model achieves the performance of 93.8% in sensitivity, 88.8% in specificity, 91.3% in accuracy and 0.971 of AUC value, which is significantly higher than the previous DNA sequence-based or protein sequence-based methods. Furthermore, our study also suggested the roles of individual features for prediction of SNPs. The most important features consist of the amino acid type, the number of available codons, position-specific scoring matrix and phylogenetic entropy. The improved model will be a promising tool for SNP predictions, and assist in the research of genome mutation and personalized prescriptions.


Asunto(s)
Secuencia de Aminoácidos , Aminoácidos , Sistema Enzimático del Citocromo P-450/genética , Modelos Moleculares , Mutación , Polimorfismo de Nucleótido Simple , Máquina de Vectores de Soporte , Área Bajo la Curva , Inteligencia Artificial , Secuencia de Bases , Codón , Biología Computacional , Sistema Enzimático del Citocromo P-450/química , Lógica Difusa , Humanos , Filogenia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...